Kris Desrosiers has a broad-based corporate practice focusing on mergers and acquisitions, private equity investment, and general corporate matters.

Mr. Desrosiers represents public and private companies, including private equity firms and strategic investors, in a variety of cross-border transactions across a range of industries, including:

  • Chemicals
  • Education
  • Energy
  • Financial services
  • Life sciences
  • Manufacturing
  • Private placements
  • Technology

Mr. Desrosiers’ experience includes advising:

  • TPG in the US$489 million acquisition of a stake in Dream Cruises*
  • MBK Partners in the US$1.75 billion (including debt) take-private of eHi Car Services*
  • Alibaba Group in connection with:
    • US$2 billion acquisition of Kaola*
    • The acquisition of Ejoy Technology*
  • US$1 billion merger between 58 Suyun and Gogovan*
  • The primary and secondary purchase of shares of Bilibili*
  • Advent International in the acquisition of a controlling stake in BioDuro*
  • Shanghai Pharmaceuticals in the US$1.2 billion acquisition of the China distribution business of Cardinal Health*
  • Hillhouse Capital in the US$101 million PIPE investment in China Biologic Products Holdings*
  • Baring Private Equity Asia in connection with:
    • US$300 million acquisition of Wall Street English*
    • US$4.3 billion take-private of Nord Anglia Education*
  • Mr. Jinbo Yao (Founder, Chairman, and CEO of in the US$8.7 billion take-private of*

*Matter handled prior to joining the firm

Bar Qualification

  • New York


  • JD, Boston University School of Law, 2009
    magna cum laude
  • BA, Boston University, 2004
    summa cum laude

Languages Spoken

  • English